- Acasti Pharma Inc KOL Event TranscriptOct 11, 2023
- Acasti Pharma Inc Annual Shareholders Meeting TranscriptOct 10, 2023
- Acasti Pharma Inc at Lytham Partners Spring Investor Conference (Virtual) TranscriptMay 18, 2023
- Acasti Pharma Inc at Oppenheimer Healthcare Conference (Virtual) TranscriptMar 13, 2023
- Q3 2023 Acasti Pharma Inc Earnings Call TranscriptFeb 14, 2023$3.99 (+3.28%)Earnings
- Acasti Pharma Inc GTX-101 and GTX-102 Call TranscriptJan 10, 2023
- Q2 2023 Acasti Pharma Inc Earnings Call TranscriptNov 14, 2022$3.12 (+3.38%)Earnings
- Q1 2023 Acasti Pharma Inc Earnings Call TranscriptAug 11, 2022$5.4 (+1.35%)Earnings
- Q4 2022 Acasti Pharma Inc Earnings Call TranscriptJun 21, 2022$5.59 (+0.12%)Earnings
- Acasti Pharma Inc Announces Positive Results for Pharmacokinetic Bridging Study Call TranscriptMay 18, 2022
- Acasti Pharma Inc at B Riley Neuro & Ophthalmology Conference (Virtual) TranscriptApr 28, 2022
- Q3 2022 Acasti Pharma Inc Earnings Call TranscriptFeb 14, 2022$7.32 (+7.02%)Earnings
- Q2 2022 Acasti Pharma Inc Earnings Call TranscriptNov 10, 2021$10.02 (-1.18%)Earnings
- Acasti Pharma Inc Planned Acquisition of Grace Therapeutics Inc Call TranscriptAug 04, 2021
- Acasti Pharma Inc Annual Shareholders Meeting TranscriptSep 30, 2020
- Q4 2020 Acasti Pharma Inc Earnings Call TranscriptJun 29, 2020$22.76 (-14.58%)Earnings
- Q3 2020 Acasti Pharma Inc Earnings Call TranscriptFeb 14, 2020$27.36 (-1.55%)Earnings
- Q2 2020 Acasti Pharma Inc Earnings Call TranscriptNov 13, 2019$98.88 (-3.29%)Earnings
- Q1 2020 Acasti Pharma Inc Earnings Call TranscriptAug 14, 2019$98.4 (+6.22%)Earnings
- Q4 2019 Acasti Pharma Inc Earnings Call TranscriptJun 26, 2019$57.6 (+14.29%)Earnings
Q1 2020 Acasti Pharma Inc Earnings Call Transcript
Good day, ladies and gentlemen, and thank you all for joining us for this Acasti Pharma First Quarter 2020 Earnings Conference Call. (Operator Instructions) Also a reminder, today's webinar is being recorded. (Operator Instructions) And now to get us started with opening remarks and introductions, I am pleased to turn the floor to David Waldman, Investor Relations for Acasti Pharma. Welcome, David.
(technical difficulty)
(Operator Instructions) Ladies and gentlemen, I do apologize for the delay and I believe we may have lost connection with our primary speaker site. Please standby one the line one moment while we attempt to reconnect.
And ladies and gentlemen, this is your operator, [Jim]. Please standby on the line while we attempt to reconnect.
Ladies and gentleman, thank you all for your patience. David, please go ahead. Your audience is listening.
Thank you. Good afternoon, everyone, and welcome to Acasti Pharma's first quarter fiscal 2020 conference
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)